Combination of mesenchymal stem cells and three-dimensional collagen scaffold preserves ventricular remodeling in rat myocardial infarction model

doi:10.4252/wjsc.v14.i8.633

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5508)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-10) series, Tables (1-4) series.

Item

Count

PDF

253

WORD

HTML

2292

Figures (1-10)

236

Tables (1-4)

226

Sum=3058

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

403

Download

796

Sum=1199

Publishing Process of This Article

Item

Count

Browse

364

Download

887

Sum=1251

Aug 26, 2022 (publication date) through Feb 6, 2025

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Stem Cells. Aug 26, 2022; 14(8): 633-657
Published online Aug 26, 2022. doi: 10.4252/wjsc.v14.i8.633

Table 1 Details of cardiac specific gene primers

No.	Gene primers	Primer sequences (5׳-3׳)	Product size
1	GAPDH (F)	GGAAAGCTGTGGCGTGATGG	414
1	GAPDH (R)	GTAGGCCATGAGGTCCACCA	414
2	GATA4 (F)	TCTCACTATGGGCACAGCAG	245
2	GATA4 (R)	CCGAGCAGGAATTTGAAGAG	245
3	cTnT (F)	TTCGACCTGCAGGAAAAGTT	206
3	cTnT (R)	GTGCCTGGCAAGACCTAGAG	206
4	Nkx2.5 (F)	ACCGCCCCTACATTTTATCC	230
4	Nkx2.5 (R)	GACAGGTACCGCTGTTGCTT	230
5	Connexin43 (F)	GCTCCACTCTCGCCTATGTC	234
5	Connexin43 (R)	GAGTTCATGTCCAGCAGCAA	234
6	cMHC (F)	GCAGGTGGATGATCTGGAGG	116
6	cMHC (R)	CCATGATGCTCTCCTGGGTC	116
7	Tbx20 (F)	TGATTCTGGCCCTAGGAAAGTG	100
7	Tbx20 (R)	TGAGCCTGGGTTCTCCATAAAG	100
8	ANF (F)	CCTGCGAAGATCAAGCTGC	110
8	ANF (R)	GCTCGAGCAGATTTGGCTG	110
9	cTnI (F)	GACCTGCGTGGCAAGTTTA	139
9	cTnI (R)	CCTCCTTCTTCACCTGCTTG	139
10	Mef2c (F)	GAGATACCCACAACACACGC	117
10	Mef2c (R)	GAGTGGAATTCGTTCCGGTG	117

F: Forward; R: Reverse; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; cTnT: Cardiac troponin T; cMHC: Cardiac myosin heavy chain; Tbx20: T-box transcription factor 20; ANF: Atrial natriuretic factor; cTnI: Cardiac troponin I; Mef2C: Myocyte-specific enhancer-binding factor 2C.

Table 2 Degrees of freedom (in vitro experiments)

Experiment	Degrees of freedom (F)
MTT assay	F_3,8 = 404.312
Gene expression
GATA4	F_3,8 = 14.883
cTnT	F_3,8 = 15.870
cTnI	F_3,8 = 34.024
Nkx2.5	F_3,8 = 15.901
cMHC	F_3,8 = 85.276
Connexin43	F_3,8 = 19.912
ANF	F_3,8 = 7.510
Tbx20	F_3,8 = 22.877
Mef2C	F_3,8 = 7.660
Protein expression
Percent positive cells
GATA4	F_3,8= 26.609
cTnT	F_3,8 = 46.829
Nkx2.5	F_3,8 = 513.556
Fluorescence intensity
GATA4	F_3,8 = 9.696
cTnT	F_3,8 = 28.438
Nkx2.5	F_3,12 = 59.175

cTnT: Cardiac troponin T; cTnI: Cardiac troponin I; cMHC: Cardiac myosin heavy chain; ANF: Atrial natriuretic factor; Tbx20: T-box transcription factor 20; Mef2C; Myocyte-specific enhancer-binding factor 2C.

Table 3 Echocardiographic parameters

Groups	Duration	LVIDd (cm)	LVIDs (cm)	EF%	FS%	EDV (mL)	ESV (mL)	SV (mL)
Sham control	2 wk	0.4194	0.1639	93.5889	60.9556	0.0722	0	0.0667
MI + ve		0.5156	0.3722	62.5556	28.3056	0.1389	0.05	0.1056
MI + scaffold		0.5193	0.332	74.4467	37.3067	0.1533	0.04	0.1133
MI + MSC-seeded scaffold		0.4461	0.2611	78.8	40.9389	0.1167	0	0.0667
MI + zebularine treated MSC-seeded scaffold		0.5144	0.2972	80.2111	42.1278	0.1444	0	0.1278
Sham control	4 wk	0.4705	0.195	92.7389	59.2222	0.1222	0	0.1111
MI + ve		0.5780	0.4363	57.3306	24.9194	0.1889	0.0833	0.1222
MI + scaffold		0.47	0.305	73.1056	36.3278	0.1222	0.0333	0.0833
MI + MSC-seeded scaffold		0.5772	0.3455	78.0056	40.5667	0.2111	0.0389	0.1667
MI + zebularine treated MSC-seeded scaffold		0.5338	0.285	82.6056	45.6611	0.1667	0	0.1222
Sham control	6 wk	0.5183	0.2333	90.3333	54.8667	0.15	0	0.1333
MI + ve		0.7066	0.5716	46.85	19.55	0.3444	0.2	0.1611
MI + scaffold		0.5472	0.3622	70.0444	33.8889	0.1667	0.0389	0.1278
MI + MSC-seeded scaffold		0.5533	0.3288	78.05	40.8611	0.1722	0.0333	0.1444
MI + zebularine treated MSC-seeded scaffold		0.5589	0.3156	81.7028	43.7972	0.17778	0.0167	0.1528

LVIDd: Left ventricular internal diameter diastole; LVIDs: Left ventricular internal diameter systole; EF: Ejection fraction; FS: Fractional shortening; EDV: End diastolic volume; ESV: End systolic volume; SV: Stroke volume; MI: Myocardial infarction; MSC: Mesenchymal stem cells.

Table 4 Degrees of freedom (in vivo experiments)

Experiments		Degrees of freedom (F)
Cardiac function analysis	Parameters	Duration, 2 wk		Duration, 4 wk	Duration, 6 wk
	LVIDd	F_4,25= 1.936		F_4,25= 1.299	F_4,25= 3.594
	LVIDs	F_4,25= 9.060		F_4,25= 6.944	F_4,25= 14.008
	%EF	F_4,25= 26.475		F_4,25= 18.378	F_4,25= 24.089
	%FS	F_4,25= 35.299		F_4,25= 24.143	F_4,25= 26.754
	EDV	F_4,25= 1.571		F_4,25= 1.059	F_4,25= 3.601
	ESV	F_4,25= 3.44		F_4,25= 5.339	F_4,25= 9.580
	SV	F_4,25= 2.305		F_4,25= 0.477	F_4,25= 0.262
Immunohistochemistry	α-SMA	F_4,10= 31.551
Cell tracking	Fluorescence intensities of cardiac specific proteins
	cMHC		F = 1.631
	cTnI		F = 0.882
	cTnT		F = 2.665
	Fluorescence intensities of DiI labeled cells
	cMHC		F = 0.398
	cTnI		F = 0.089
	cTnT		F = 0.039

LVIDd: Left ventricular internal diameter diastole; LVIDs: Left ventricular internal diameter systole; EF: Ejection fraction; FS: Fractional shortening; EDV: End diastolic volume; ESV: End systolic volume; SV: Stroke volume; α-SMA: α-smooth muscle actin; cMHC: Cardiac myosin heavy chain; cTnI: Cardiac troponin I; cTnT: Cardiac troponin T.

Citation: Qazi REM, Khan I, Haneef K, Malick TS, Naeem N, Ahmad W, Salim A, Mohsin S. Combination of mesenchymal stem cells and three-dimensional collagen scaffold preserves ventricular remodeling in rat myocardial infarction model. World J Stem Cells 2022; 14(8): 633-657
URL: https://www.wjgnet.com/1948-0210/full/v14/i8/633.htm
DOI: https://dx.doi.org/10.4252/wjsc.v14.i8.633